Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as $292.64 and last traded at $291.68, with a volume of 621039 shares changing hands. The stock had previously closed at $276.16.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
The stock has a 50-day moving average price of $195.18 and a 200 day moving average price of $177.15.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Large investors have recently added to or reduced their stakes in the stock. Halbert Hargrove Global Advisors LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares during the first quarter valued at $166,000. Barclays PLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth about $893,000. Renaissance Technologies LLC raised its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 10.6% during the 4th quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock worth $3,650,000 after purchasing an additional 2,200 shares during the last quarter. Foundations Investment Advisors LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at about $797,000. Finally, SLT Holdings LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter valued at about $797,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
